The US FDA has approved the QLOSI eye drops, from Israel’s Orasis (see here previously), The prescription eye drops improve farsightedness (presbyopia) for up to eight hours without impacting distance or night vision. The treatment can benefit almost two billion … Continue reading →

As reported previously (Sep 2018) Israel’s Orasis has developed CSF-1 (eye drops) to treat presbyopia – age-related far-sightedness. Results of Phase 2b trials of CSF-1 showed “significant improvement”, together with “exceptional safety and tolerability”. https://www.orasis-pharma.com/orasis-pharmaceuticals-announces-csf-1-eye-drop-successfully-met-primary-endpoint-in-phase-2b-clinical-study-in-presbyopia/

I reported previously (18th Mar) that Israeli scientists were developing eye drops to improve vision. Israeli startup Orasis is also working on eye drops to treat presbyopia – age-related far-sightedness due to loss of elasticity in the lens of the … Continue reading →